Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             129 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accelerated hypofractionated radiotherapy for non small cell lung cancer: Pooled results from 4 UK centres Din, O.
 2010
 67 S1 p. S31-S32
2 p.
 artikel
2 Achieving optimal performance of a new endobronchial ultrasound service: The effect of supervision and case selection Lal, A.
 2010
 67 S1 p. S15-
1 p.
 artikel
3 Adjuvant chemotherapy for non-small cell lung cancer: The need for a further trial in the context of the new (seventh) TNM staging system for Lung and Pleura Aynsley, E.
 2010
 67 S1 p. S16-
1 p.
 artikel
4 After induction treatment, radiotherapy is not superior to surgery for N2 disease: A meta-analysis of randomised trials Sadri, A.
 2010
 67 S1 p. S38-
1 p.
 artikel
5 A Kent and Medway Cancer Network (KMCN) audit of second-line treatment for non-small cell lung cancer Cafferkey, C.
 2010
 67 S1 p. S7-S8
2 p.
 artikel
6 An audit of carboplatin and vinorelbine (CarboVIn) chemotherapy for NSCLC in Gwent Othman, E.
 2010
 67 S1 p. S4-
1 p.
 artikel
7 An audit of patients admitted with symptomatic lung cancer Can admissions be avoided? Bell, N.
 2010
 67 S1 p. S25-S26
2 p.
 artikel
8 An audit of the use and utility of erlotinib at Weston Park Hospital, Sheffield UK Wilson, C.
 2010
 67 S1 p. S5-S6
2 p.
 artikel
9 An examination of the recruitment of non-small cell lung cancer (NSCLC) patients with brain metastases to QUARTZ and TACTIC clinical trials in a UK cancer centre Bayman, N.
 2010
 67 S1 p. S31-
1 p.
 artikel
10 An exploration of palliative care nurse specialists' understanding of suffering Davies, H.M.
 2010
 67 S1 p. S24-
1 p.
 artikel
11 A nurse-led telephone based review for patients with NSCLC receiving oral vinorelbine Gunter, T.
 2010
 67 S1 p. S7-
1 p.
 artikel
12 A phase 1 trial of the MEK1/2 inhibitor AZD6244 in combination with thoracic radiotherapy in advanced non-small cell lung cancer (NSCLC) Koh, P. Keng
 2010
 67 S1 p. S33-S34
2 p.
 artikel
13 A retrospective audit of patients who received erlotinib for non-small cell lung cancer White, J.
 2010
 67 S1 p. S26-
1 p.
 artikel
14 A retrospective study of disease recurrence post thoracotomy for non-small cell lung cancer Navani, N.
 2010
 67 S1 p. S38-S39
2 p.
 artikel
15 A role for IGF-1R targeted therapy in SCLC? Gately, K.
 2010
 67 S1 p. S12-
1 p.
 artikel
16 A single institution experience of adjuvant chemotherapy for resected NSCLC Taylor, P.
 2010
 67 S1 p. S8-
1 p.
 artikel
17 Atypical facial pain as the first presentation of mediastinal relapse in lung cancer Jones, C.A.
 2010
 67 S1 p. S13-S14
2 p.
 artikel
18 Audit of adjuvant vinorelbine and cisplatin for patients with resected NSCLC Alzouebi, M.
 2010
 67 S1 p. S3-
1 p.
 artikel
19 Audit of assessment of fitness for radical therapy in lung cancer Magee, N.
 2010
 67 S1 p. S42-
1 p.
 artikel
20 Audit of a support group for people affected by mesothelioma Moore, S.
 2010
 67 S1 p. S27-S28
2 p.
 artikel
21 Author index 2010
 67 S1 p. S43-S46
4 p.
 artikel
22 Benefits of home visits for post-thoracotomy patients by thoracic surgical liaison nurses Alexander, D.
 2010
 67 S1 p. S29-
1 p.
 artikel
23 ‘Better safe than sorry’ improving practice by the introduction of a PleurX catheter “Alert” card Maguire, J.
 2010
 67 S1 p. S28-
1 p.
 artikel
24 Building and implementing a lung stereotactic body radiotherapy (SBRT) programme in a non-academic radiotherapy centre The Middlesbrough experience Peedell, C.
 2010
 67 S1 p. S30-
1 p.
 artikel
25 Case report – Extraordinary survival with multiple primaries Khan, H.
 2010
 67 S1 p. S41-
1 p.
 artikel
26 Chemotherapy does not increase the risk of pleural infection in patients managed with an indwelling pleural catheter for malignant pleural effusion Morel, A.
 2010
 67 S1 p. S6-S7
2 p.
 artikel
27 Chemotherapy review: Moving to a shared care model Burcombe, R.
 2010
 67 S1 p. S9-
1 p.
 artikel
28 Comparing toxicity profiles of oral and intravenous vinorelbine in patients with advanced NSCLC McPhelim, J.
 2010
 67 S1 p. S5-
1 p.
 artikel
29 Comparison of CT and CT-PET for the pre-operative staging of non small cell lung cancer Free, C.M.
 2010
 67 S1 p. S14-
1 p.
 artikel
30 Comparison of Northern Ireland Cancer Network to LUCADA headline figures (2006) McLaughlin, L.M.
 2010
 67 S1 p. S22-S23
2 p.
 artikel
31 Concurrent chemotherapy and radiotherapy in NSCLC: Northampton experience Eldeeb, H.
 2010
 67 S1 p. S30-
1 p.
 artikel
32 CONVERT: Concurrent once-daily versus twice-daily radiotherapy A phase III randomised controlled trial for patients with limited stage small cell lung cancer and good performance status Faivre-Finn, C.
 2010
 67 S1 p. S11-
1 p.
 artikel
33 Day case cisplatin for advanced non-small cell lung cancer Harrington, J.
 2010
 67 S1 p. S8-
1 p.
 artikel
34 30 day mortality in lung cancer patients treated with chemotherapy in SE Wales: A review in light of the NCEPOD report Howe, T.
 2010
 67 S1 p. S8-
1 p.
 artikel
35 Defining target volumes for treatment of peripheral lung tumours with radiotherapy: A comparison of 18F-FDG-positron emission tomography and 4-dimensional CT scanning Hanna, G.G.
 2010
 67 S1 p. S32-
1 p.
 artikel
36 Detection of clinically silent brain metastases in stage IIIA lung cancer Thomas, A.
 2010
 67 S1 p. S16-
1 p.
 artikel
37 Developing a lung cancer CNS telephone follow up and support clinic Williams, N.
 2010
 67 S1 p. S25-
1 p.
 artikel
38 Development of non-medical prescriber team to support lung cancer clinic Williamson, S.
 2010
 67 S1 p. S23-
1 p.
 artikel
39 Does size matter? An audit of dose intensity in non-small cell lung cancer Peedell, C.
 2010
 67 S1 p. S3-
1 p.
 artikel
40 Dosimetric consequences of contrast-enhanced CT planning for thoracic radiotherapy Lalondrelle, S.
 2010
 67 S1 p. S35-S36
2 p.
 artikel
41 Do we need another randomised controlled trial of prophylactic irradiation of tracts in patients with malignant pleural mesothelioma following invasive chest wall intervention? Bayman, N.
 2010
 67 S1 p. S19-
1 p.
 artikel
42 Early experience with the Hitachi-Pentax EB-1970UK EBUS bronchoscope for the investigation of mediastinal/hilar adenopathy Barlow, A.
 2010
 67 S1 p. S12-S13
2 p.
 artikel
43 Early results of lung stereotactic body radiotherapy for inoperable stage I NSCLC at the St. James's Institute of Oncology, Leeds Sivapalasuntharam, A.
 2010
 67 S1 p. S36-
1 p.
 artikel
44 Early sequential PET scanning and use of modified RECIST criteria in the evaluation of malignant pleural mesothelioma (MPM) O'Flaherty, J.
 2010
 67 S1 p. S20-
1 p.
 artikel
45 Editorial Board 2010
 67 S1 p. ii-
1 p.
 artikel
46 Erlotinib: Introducing a collaborative approach to enhance patient experience Farrow, L.
 2010
 67 S1 p. S26-
1 p.
 artikel
47 Erlotinib prescribing for the second-line treatment of non-small cell lung cancer (NSCLC): The effect of National Institute for Health and Clinical Excellence (NICE) Technology Appraisal 162 (TA162) Banner, R.
 2010
 67 S1 p. S6-
1 p.
 artikel
48 Establishing a lung cancer information and support group in the Northern Health and Social Care Trust (NHSCT), Northern Ireland Conlon, M.
 2010
 67 S1 p. S27-
1 p.
 artikel
49 Evaluating the safety of using G-CSF prophylaxis during concurrent thoracic chemo-radiotherapy (CTRT) in patients with limited-disease small-cell lung cancer (LD-SCLC): Evidence from a phase II trial Sheikh, H.Y.
 2010
 67 S1 p. S10-S11
2 p.
 artikel
50 Evaluation of c-FLIP as a target for vorinostat in mesothelioma Hurwitz, J.
 2010
 67 S1 p. S1-
1 p.
 artikel
51 Examination of 12-lipoxygenase as a therapeutic target in non-small cell lung cancer (NSCLC): Mechanisms controlling survival and induction of apoptosis following selective inhibition Cathcart, M.C.
 2010
 67 S1 p. S1-S2
2 p.
 artikel
52 Facilitating early discharge Pollock, S.
 2010
 67 S1 p. S25-
1 p.
 artikel
53 Follow up of patients with lung cancer receiving radical radiotherapy: Continuous hyperfractionated accelerated radiotherapy (CHART) treatment Roy, K.
 2010
 67 S1 p. S29-S30
2 p.
 artikel
54 Functional outcome in patients with non-small cell lung cancer who failed BTS recommended post-operative predicted criteria for lung resection Pattenden, H.
 2010
 67 S1 p. S37-
1 p.
 artikel
55 High coexpression of both the epidermal growth factor receptor (EGFR) and insulin-like growth factor receptor-1 (IGF-1R) correlates with a poor patient prognosis in resected non-small cell lung cancer (NSCLC) Gately, K.
 2010
 67 S1 p. S3-
1 p.
 artikel
56 High dose palliative radiotherapy for non-small cell lung cancer: Should it be computer planned? Borthwick, K.
 2010
 67 S1 p. S35-
1 p.
 artikel
57 Histological evaluation of mediastinal pathology with EBUS-TBNA: The Leicester series Free, C.M.
 2010
 67 S1 p. S15-S16
2 p.
 artikel
58 How does gene expression profile for lung cancer change based on the timing of acquisition? A preliminary study Sadri, A.
 2010
 67 S1 p. S2-
1 p.
 artikel
59 Hyperpolarized helium-3 MRI assessment of radiation-induced lung injury Hatton, M.Q.
 2010
 67 S1 p. S35-
1 p.
 artikel
60 Impact of lung cancer nurse specialist interventions and contact card Bolton, S.
 2010
 67 S1 p. S25-
1 p.
 artikel
61 Impact of NICE guidelines on mediastinal staging strategies Ahmed, I.M.
 2010
 67 S1 p. S16-S17
2 p.
 artikel
62 Implementation of stereotactic body radiotherapy (SBRT) for non small cell lung cancers in the UK Jain, P.
 2010
 67 S1 p. S34-S35
2 p.
 artikel
63 Improving chemotherapy capacity by switching from intravenous to oral vinorelbine: TAMINO, an international time and motion audit James, R.
 2010
 67 S1 p. S4-
1 p.
 artikel
64 Improving communication pathways in a multi-disciplinary trials team has led to increased patient recruitment Woolley, S.
 2010
 67 S1 p. S42-
1 p.
 artikel
65 Inaccurate clinical nodal staging of non-small cell lung cancer: Evidence from the MRC LU22 multi-centre randomised trial Navani, N.
 2010
 67 S1 p. S17-
1 p.
 artikel
66 Individualised chemotherapy for non-small cell lung cancer (NSCLC): Nine months' experience in the North of England Cancer Network (NECN) Jones, C.
 2010
 67 S1 p. S9-
1 p.
 artikel
67 Influence of case-mix adjustment on outcomes in the National Lung Cancer Audit Woolhouse, I.
 2010
 67 S1 p. S22-
1 p.
 artikel
68 Influence of co-morbidity on renal function estimation by Cockcroft Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy Hubner, R.
 2010
 67 S1 p. S9-
1 p.
 artikel
69 Lanarkshire lung cancer information and support sessions: A new patient venture in collaboration with Maggie's Lanarkshire Irvine, L.
 2010
 67 S1 p. S28-
1 p.
 artikel
70 Long-term survivors after surgical management of malignant pleural mesothelioma Balduyck, B.
 2010
 67 S1 p. S17-S18
2 p.
 artikel
71 Lung cancer and delay in diagnosis Alwan, Y.
 2010
 67 S1 p. S14-
1 p.
 artikel
72 Lymph nodes dissection, implication on prognosis in surgical non-small cell lung cancer Al-Alao, B.
 2010
 67 S1 p. S37-
1 p.
 artikel
73 Lymphoma presenting to respiratory medicine at a district general hospital in the UK Khan, D.
 2010
 67 S1 p. S21-
1 p.
 artikel
74 Management of small cell lung cancer in the West of Scotland Clark, B.
 2010
 67 S1 p. S11-
1 p.
 artikel
75 Maximising recruitment to lung cancer trials, a single centre experience of the FRAGMATIC trial Smith, C.
 2010
 67 S1 p. S22-
1 p.
 artikel
76 Memorial service Phelps, J.
 2010
 67 S1 p. S27-
1 p.
 artikel
77 Mesothelioma in the Kent and Medway Cancer Network: A comprehensive review of 2 years of pemetrexed-based chemotherapy Mikropoulos, C.
 2010
 67 S1 p. S18-
1 p.
 artikel
78 Neurosurgery for brain metastases (BM) in the management of non-small cell lung cancer (NSCLC): A retrospective study of all cerebral metastasectomies at St George's Hospital London (SGH), 1999–2009 Goldstein, R.
 2010
 67 S1 p. S38-
1 p.
 artikel
79 New tricks for an old dog: Gemcitabine is a DNA methyltransferase inhibitor Gray, S.G.
 2010
 67 S1 p. S2-
1 p.
 artikel
80 NICE guidance and percutaneous interventions for superior vena cava obstruction Woolnough, K.
 2010
 67 S1 p. S41-S42
2 p.
 artikel
81 Omitting elective nodal irradiation (ENI) during thoracic irradiation in limited-stage small cell lung cancer (LS-SCLC) Patterns of failure from a phase II trial Colaco, R.
 2010
 67 S1 p. S10-
1 p.
 artikel
82 Oral vinorelbine for non small cell lung cancer: Is the day 8 full blood count worthwhile? Caley, A.
 2010
 67 S1 p. S3-S4
2 p.
 artikel
83 Outcome for patients with operable non-small cell lung cancer (NSCLC) in Mid-Western Ireland Quintyne, K.I.
 2010
 67 S1 p. S4-S5
2 p.
 artikel
84 Palliative radiotherapy for non-small cell lung carcinoma Powell, J.
 2010
 67 S1 p. S30-
1 p.
 artikel
85 Patient evaluation and experience of a lung cancer support group Henderson, K.
 2010
 67 S1 p. S26-
1 p.
 artikel
86 Peripheral blood eosinophil count correlates with survival in lung cancer Shelton, A.
 2010
 67 S1 p. S40-S41
2 p.
 artikel
87 PET/CT has enabled the development of a non invasive strategy for mediastinal staging in non small cell lung cancer (NSCLC) Ahmed, I.
 2010
 67 S1 p. S16-
1 p.
 artikel
88 Positive and negative immune components in the tumour environment in malignant pleural mesothelioma: Tumor-antigen-specific T-cells vs. immunosuppressive effects Tabi, Z.
 2010
 67 S1 p. S20-S21
2 p.
 artikel
89 Positive reappraisal of the impact of working with patients who are suffering: A study of palliative care nurse specialists' experience Davies, H.M.
 2010
 67 S1 p. S24-
1 p.
 artikel
90 Post diagnosis home visits improve patient journey in lung cancer Palmer, M.
 2010
 67 S1 p. S28-S29
2 p.
 artikel
91 Pre-treatment tumour volume A critical predictive factor for survival after radiotherapy or chemoradiotherapy for locally advanced non-small-cell lung cancer (LA-NSCLC) Gray, E.
 2010
 67 S1 p. S34-
1 p.
 artikel
92 Prevention of skin metastasis in malignant mesothelioma with prophylactic irradiation of tracts (PIT): Is the difference in research evidence due to the discrepancy between distance from pleural entry point and the skin scar? Hambleton, K.
 2010
 67 S1 p. S19-
1 p.
 artikel
93 Quality improvement in lung cancer: Aims and achievements in the North of Scotland Nicolson, M.
 2010
 67 S1 p. S23-
1 p.
 artikel
94 Quality improvement standards in lung cancer: Fact or fantasy in the North of Scotland? Nicolson, M.
 2010
 67 S1 p. S21-
1 p.
 artikel
95 Quality of life in patients receiving optimal supportive care (including dexamethasone) plus whole-brain radiotherapy in the treatment of inoperable brain metastases from non-small cell lung cancer: The MRC QUARTZ randomised trial Mulvenna, P.
 2010
 67 S1 p. S31-
1 p.
 artikel
96 RADAR Radiation damage and resistance in patients with lung cancer Koh, P.K.
 2010
 67 S1 p. S32-S33
2 p.
 artikel
97 Radial radiotherapy versus high dose palliative radiotherapy with or without chemotherapy in non small cell lung carcinoma (NSCLC): Retrospective analysis of overall survival Brulinski, P.
 2010
 67 S1 p. S33-
1 p.
 artikel
98 Re-challenge gemcitabine carboplatin in the “second-line” setting Hayat Khan, K.
 2010
 67 S1 p. S7-
1 p.
 artikel
99 Reported outcomes of patients undergoing radical concurrent chemoradiation for non-small cell lung cancer (NSCLC) at Guy's and St. Thomas' (GSTT) NHS Foundation Trust Suh, Y.
 2010
 67 S1 p. S39-S40
2 p.
 artikel
100 Reproducibility and efficiency of Varian Cone Beam CT for frameless SBRT verification Heaton, A.
 2010
 67 S1 p. S34-
1 p.
 artikel
101 RON receptor tyrosine kinase as a potential translational therapeutic target in malignant pleural mesothelioma Easty, D.
 2010
 67 S1 p. S19-S20
2 p.
 artikel
102 Safe introduction and early outcomes of stereotactic body radiotherapy for early stage medically inoperable non small cell lung cancer Jain, P.
 2010
 67 S1 p. S35-
1 p.
 artikel
103 Second line chemotherapy for NSCLC: Northampton experience Reza, S.
 2010
 67 S1 p. S6-
1 p.
 artikel
104 Should brain imaging be included in staging prior to radical concurrent chemoradiation for non-small cell lung cancer (NSCLC) patients in the UK? Suh, Y.
 2010
 67 S1 p. S13-
1 p.
 artikel
105 Should patients with bone metastases in advanced non-small cell lung cancer be treated any differently than other stage IV patients? McAleese, J.
 2010
 67 S1 p. S41-
1 p.
 artikel
106 Significant response to carboplatin/pemetrexed chemotherapy in malignant pleural mesothelioma Fullam, L.
 2010
 67 S1 p. S20-
1 p.
 artikel
107 Small cell lung cancer in the National Lung Cancer Audit Beckett, P.
 2010
 67 S1 p. S10-
1 p.
 artikel
108 Small cell lung cancer (SCLC): Selecting patients for chemotherapy is more complex than just assessing performance status Masson, S.
 2010
 67 S1 p. S11-
1 p.
 artikel
109 Small cell lung carcinoma following adjuvant breast radiotherapy in a non-smoker Davies, C.E.
 2010
 67 S1 p. S12-
1 p.
 artikel
110 Smoking and lung cancer education in secondary schools: The Stockton project Draffan, J.
 2010
 67 S1 p. S40-
1 p.
 artikel
111 Smoking in teenagers Carter, L.
 2010
 67 S1 p. S39-
1 p.
 artikel
112 South-Asian patients' access to lung cancer services at Birmingham Heartlands Hospital Alzetani, A.
 2010
 67 S1 p. S23-S24
2 p.
 artikel
113 Support needs following a diagnosis of lung cancer: The patient's perspective Samson, M.
 2010
 67 S1 p. S24-
1 p.
 artikel
114 Surgery for small cell lung cancer (SCLC), where are the patients? Montes, A.
 2010
 67 S1 p. S11-S12
2 p.
 artikel
115 Surgical resection for non-small cell lung cancer: Clinical features and outcomes for a consecutive series at an Irish tertiary referral centre Al-Alao, B.
 2010
 67 S1 p. S37-
1 p.
 artikel
116 Survival in patients with non-small cell lung cancer and brain metastases Lwin, M. Thit
 2010
 67 S1 p. S32-
1 p.
 artikel
117 Systemic inflammation as measured by Glasgow prognostic score in lung cancer patients Mohammed, N.
 2010
 67 S1 p. S15-
1 p.
 artikel
118 TELECLINIC: A nurse led telephone follow-up clinic for lung cancer patients: Improving the patient's experience Drury, G.
 2010
 67 S1 p. S24-
1 p.
 artikel
119 The generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines Barr, M.
 2010
 67 S1 p. S2-
1 p.
 artikel
120 The IGF-1R pathway in NSCLC. Expression, mutational analysis and activation by hypoxia Forde, L.
 2010
 67 S1 p. S1-
1 p.
 artikel
121 The limited clinical benefit of respiration gated radiotherapy (RGRT) in non-small cell lung cancer (NSCLC) Muirhead, R.
 2010
 67 S1 p. S30-S31
2 p.
 artikel
122 The National Lung Cancer Audit Headline results in year 4 Beckett, P.
 2010
 67 S1 p. S21-S22
2 p.
 artikel
123 The National Lung Cancer Forum for Nurses guidelines on palliative radiotherapy for lung cancer Mencnarowski, J.
 2010
 67 S1 p. S27-
1 p.
 artikel
124 The prognostic significance of intra-tumoural vascular invasion in surgically resected non-small cell lung cancer Al-Alao, B.
 2010
 67 S1 p. S38-
1 p.
 artikel
125 The use of a liquid-based thin-layer cytology technique in transbronchial needle aspiration for suspected lung cancer A retrospective 2-year single centre analysis Shah, A.
 2010
 67 S1 p. S13-
1 p.
 artikel
126 Toxicity of hypofractionated accelerated radiotherapy concomitant with cisplatin/vinorelbine chemotherapy for non small cell lung cancer Mohammed, N.
 2010
 67 S1 p. S36-
1 p.
 artikel
127 Treatment of stage I and II NSCLC with radical radiotherapy Hall, A.
 2010
 67 S1 p. S36-S37
2 p.
 artikel
128 VISUAL: Clinical implementation of volumetric modulated arc therapy (VMAT) image-guided stereotactic radiotherapy using active breathing control (ABC) for small volume lung tumours McDonald, F.
 2010
 67 S1 p. S29-
1 p.
 artikel
129 What is the surgical resection rate for malignant pleural mesothelioma? Khosravi, A.
 2010
 67 S1 p. S18-
1 p.
 artikel
                             129 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland